Overview

Webcast ImageWebcast
Q2 2015 Laboratory Corporation of America Holdings Earnings Conference Call (Live)
07/28/15 at 9:00 a.m. ET
Corporate Profile

Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With combined revenue pro... More >>

Recent NewsMore >>
DateTitle 
07/01/15Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
BURLINGTON, N.C.--(BUSINESS WIRE)--Jul. 1, 2015-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject to the terms of the Zero Coupon Notes and the Indenture, dated as of October 24, 2006 between LabCorp and T... 
Printer Friendly Version
06/04/15LabCorp Expands Access to LabCorp AccuDraw® to Support Better Patient Care
BURLINGTON, N.C.--(BUSINESS WIRE)--Jun. 4, 2015-- Laboratory Corporation of America® Holdings (LabCorp®) (LH: NYSE) today announced the expanded availability of its proprietary specimen collection and handling software, LabCorp AccuDraw®, to all clients through its website at www.LabCorp.com. Combining on-screen visual cues with step-by-step tutorials, AccuDraw is an innovative tool designed to guide the health care professional who collects patie... 
Printer Friendly Version
06/02/15LabCorp is Scheduled to Present at the Goldman Sachs 36th Annual Global Healthcare Conference
BURLINGTON, N.C.--(BUSINESS WIRE)--Jun. 2, 2015-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced it will participate at the Goldman Sachs 36th Annual Global Healthcare Conference. LabCorp’s presentation is planned for Tuesday, June 9, 2015 at 5:00 PM (ET). A live audio webcast will be available via the Company website at www.labcorp.com and archived for replay. About LabCorp® Labora... 
Printer Friendly Version
06/01/15Sysmex and LabCorp Announce a Strategic Collaboration for Blood-Based Molecular Testing Services and Products to Support the Development of Precision Medicine in Oncology
KOBE, Japan & BURLINGTON, N.C.--(BUSINESS WIRE)--Jun. 1, 2015-- Sysmex Corporation (TSE:6869) and Laboratory Corporation of America® Holdings (LabCorp®) (LH:NYSE) today announced a strategic collaboration focused on the development of blood-based molecular diagnostic tests to advance precision medicine in oncology. The collaboration combines Sysmex Inostics’ strength in the development of innovative blood-based diagnostic solutions with LabCorp's unp... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
07/28/15
Q2 2015 Laboratory Corporation of America Holdings Earnings Conference Call
LH (Common)
ExchangeNYSE
Price$120.75
Change Stock is Down 1.44
Intraday High$122.13
Intraday Low$120.41
Volume1,299,151
Data as of 07/02/15
4:01 p.m. ET
Minimum 20 minute delay
Refresh quote

Reports & Performance

2014 Annual Report

2013 Annual Report

2012 Annual Report

2011 Annual Report

2010 Annual Report

2009 Annual Report

2008 Annual Report

2007 Annual Report

2006 Annual Report

Latest Earnings Release